Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 19,847 | 22,897 | 19,234 | 12,894 | 10 |
| Operating Income | -19,847 | -22,897 | -19,234 | -12,894 | -10 |
| Other Income | 847 | 637 | 149 | 4 | 0 |
| Pre-tax Income | -19,000 | -22,260 | -19,085 | -12,890 | -10 |
| Net Income Continuous | -19,000 | -22,260 | -19,085 | -12,890 | -10 |
| Net Income | $-19,000 | $-22,260 | $-19,085 | $-12,890 | $-10 |
| EPS Basic Total Ops | -1.11 | -1.43 | -1.51 | -3.02 | 0.00 |
| EPS Basic Continuous Ops | -1.11 | -1.43 | -1.51 | -3.02 | 0.00 |
| EPS Diluted Total Ops | -1.11 | -1.43 | -1.51 | -3.02 | 0.00 |
| EPS Diluted Continuous Ops | -1.11 | -1.43 | -1.51 | -3.02 | 0.00 |
| EPS Diluted Before Non-Recurring Items | -1.11 | -1.43 | -1.51 | -3.02 | N/A |
| EBITDA(a) | $-19,847 | $-22,897 | $-19,234 | $-12,894 | $-10 |